Events - Spark Newswire

3 minute read

Teleflex Reaffirms FY22 Guidance Ahead Of Friday Investor Day; Event Begins At 10 a.m. EDT

Today, 6:35 AM

Teleflex Incorporated (NYSE:TFX), a leading global provider of medical devices, will provide an update on its business and address its 2023-2025 business growth strategy and financial goals during its 2022 Analyst &

TFX

2 minute read

Nio Shares Jump 20% In Singapore Debut: What You Should Know

By Rachit Vats

Today, 12:36 AM

U.S.-listed Chinese electric carmaker Nio Inc (NYSE: NIO) on Friday made its debut on the Singapore stock exchange, with shares jumping 20% in early trading, as it laid out plans to open a local research center focused on artificial intelligence and self-driving cars.

NIO

1 minute read

Akari Therapeutics Presents Results From The CASCADE And CORONET Studies In COVID-19 At The American Thoracic Society 2022 Annual Meeting

By Benzinga Newsdesk

Yesterday, 4:05 PM

Akari Therapeutics, Plc (NASDAQ:AKTX), a late-stage biotechnology company focused on developing advanced therapies for autoimmune and inflammatory diseases, presented results from the CASCADE and CORONET studies in

AKTX

3 minute read

VeeCon NFT Conference Kicks Off Today: Here Are The Details And What Benzinga Is Most Excited About

By Chris Katje

Yesterday, 11:50 AM

VeeCon 2022 kicks off Thursday, May 19 featuring speakers, panels and experiences connecting the non-fungible token community. Here are the details.

COIN

3 minute read

Celldex Announces Acceptance Of Abstract For Barzolvolimab Phase 1b Results In Chronic Spontaneous Urticaria For Late-Breaking Presentation At The European Academy Of Allergy And Clinical Immunology (EAACI) Annual Congress 2022

By Benzinga Newsdesk

Yesterday, 9:26 AM

Celldex Announces Acceptance of Abstract for Barzolvolimab Phase 1b Results in Chronic Spontaneous Urticaria for Late-Breaking Presentation at the European Academy of Allergy and Clinical Immunology (EAACI) Annual

CLDX

1 minute read

VBI Vaccines Presented Health Economics And Outcomes Research For PreHevbrio At The International Society For Pharmacoeconomics And Outcomes Research 2022

By Benzinga Newsdesk

Yesterday, 8:06 AM

VBI Vaccines Inc. (NASDAQ:VBIV) (VBI), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, today announced that health economics and outcomes research

VBIV

1 minute read

Bristol Myers Squibb Data At ASCO And EHA 2022 Highlight Progress In Transforming Treatment For Patients With Cancer And Blood Disorders

By Benzinga Newsdesk

Yesterday, 6:59 AM

Long-term data from Opdivo plus Yervoy-based combinations demonstrate durable survival in metastatic non-small cell lung cancer (NSCLC) and metastatic melanoma, including results from landmark five-year analysis of

BMY

3 minute read

EXCLUSIVE: How To Know When It’s Time To Pull The Trigger And Buy A Stock

By Adam Eckert

May 17, 5:57 PM

The core elements of every investing strategy consist of buying rules, selling rules, risk management and portfolio management.

SPY

3 minute read

EXCLUSIVE: Why Ming Zhao Says Fractional Options Trading Will Favor Retail Investors

By Jessica Abraham

May 17, 4:36 PM

Meet Ming Zhao, CEO and founder of Atomic Vaults and popularly known as @FabiusMercurius by thousands of retail traders on Twitter. She believes that the industry is systematically biased against retail investors and said she sets out to change the future of options trading by doing something rather monumental.

HOOD

2 minute read

EXCLUSIVE: Be The House Not The Gambler — How To Use Options To Improve Performance

By Michael Cohen

May 17, 4:33 PM

While investment results in the markets are not guaranteed, there are relatively simple options strategies that can greatly reduce risk and generate far more predictable returns in the long run.

AAPL